bpc-157 dosing protocol subcutaneous clinical trials dosage BPC-157 (Common Protocols), 🔹 Oral / Subcutaneous, • 500 mcg daily, • Duration: 6 weeks, 🔹 Intramuscular / Peritendinous, • 1 mg daily, • Duration: 6 weeks, ⚠️ Note:, Not approved by FDA or The Complete BPC-157 Dosage Guide:

This is not a reason to assume you are not a candidate it is a reason to let your NP know so they can make the right call for your specific situation

(2018) 9:e0212017

Geen enkel medisch, therapeutisch, diagnostisch of preventief gebruik wordt geclaimd of gesuggereerd

Some preclinical and cell-based studies have associated BPC-157 exposure with changes in migration-related behavior and adhesion-associated markers, but these findings should be interpreted within the cell type, matrix substrate, serum condition, exposure duration, and assay design used in the original experiments

She underwent a period of rest, cortisone injection and 3 months of physiotherapy without improvement